Gut Liver.  2022 Jan;16(1):81-91. 10.5009/gnl210064.

Perceptions and Behaviors of Patients with Inflammatory Bowel Disease during the COVID-19 Crisis

• Lee YJ
• Kim KO
• Kim MC
• Cho KB
• Park KS
• Jang BI
• on behalf of the Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD)

• KMID: 2524765
• DOI: http://doi.org/10.5009/gnl210064

Abstract

Background/Aims
This study aimed to investigate the perceptions and behaviors of patients with inflammatory bowel disease (IBD) during the early coronavirus disease 2019 (COVID-19) pandemic in the major epidemic area in Korea.
Methods
Between April and May 2020, a cross-sectional survey was performed at two tertiary hospitals in Daegu, South Korea, on patients’ experiences, coping strategies and perceptions.
Results
Most of the 544 patients participating in the survey strictly adhered to personal protection guidance against COVID-19. In the early COVID-19 crisis, many patients canceled or postponed hospital visits (57.5%) and rescheduled biologics administrations (26.4%). Although 13.6% utilized telemedicine, the frequency of individuals leaving their homes remained unchanged. Although 50.4% were concerned about their susceptibility to COVID-19, 72.2% adhered to their treatment for IBD. In patients taking biologics or Janus kinase inhibitors, 86.8% disagreed that they should discontinue their medication as a preventative measure against COVID-19, but 21.9% actually discontinued their medications. Of those with discordance between the perception of IBD drug adherence and active behaviors, 5.4% of all and 39.4% of biologics or Janus kinase inhibitors withheld drugs specifically due to fear of COVID-19. Only 7% of all patients discussed drug safety with their physicians. The level of concern for COVID-19 depended on the type of drug used.
Conclusions
Patients with IBD showed concerns about the increased risk of COVID-19 due to IBD or their medications, and a considerable number of patients withheld their medications without consulting medical staff. Enhanced active communications with patients with IBD and appropriate health-related education should be provided.

Keyword

Inflammatory bowel diseases; COVID-19; Perception; Medication adherence